Allergan wins appeal, blocking US generic version of Acular LS
This article was originally published in Scrip
Executive Summary
Allerganand Rochehave won a legal battle with Apotex, by prevailing in an appeals court ruling that prevents Apotex from marketing a generic version of Acular LS (ketorolac tromethamine ophthalmic solution), marketed by Allergan, until 2009.